SC 13D: Statement of acquisition of beneficial ownership by individuals-Novartis BidCo AG(11.56%),Novartis Pharma AG(11.56%), etc.
MorphoSys | SC 13G: Statement of acquisition of beneficial ownership by individuals-THE GOLDMAN SACHS GROUP, INC.(10.8 %),GOLDMAN SACHS & CO. LLC(10.8 %)
MorphoSys | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Kynam Capital Management, LP(11.13%),Kynam Capital Management GP, LLC(11.13%), etc.
MorphoSys | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-T. Rowe Price Investment Management, Inc.(4.3%)
MorphoSys | SC 13G: Statement of acquisition of beneficial ownership by individuals-Kynam Capital Management, LP(9.8%),Kynam Capital Management GP, LLC(9.8%), etc.
MorphoSys | SC 13G: Statement of acquisition of beneficial ownership by individuals-T. Rowe Price Investment Management, Inc.(4.3%)
MorphoSys | SC 13G: Statement of acquisition of beneficial ownership by individuals-T. Rowe Price Investment Management, Inc.(5.3%)
MorphoSys | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)
MorphoSys | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)
MorphoSys | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)
MorphoSys | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions
MorphoSys | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions
No Data